Publications by authors named "Mario Gaio"

Claim this Profile
A
A systematic review and pharmacovigilance analysis of the risk of agranulocytosis associated with metamizole use.
Alessia Zinzi, Mario Gaio, Donatella Ruggiero, Consiglia Riccardi, Cecilia Cagnotta

Sci Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disproportionality analysis of European safety reports on autoimmune and rheumatic diseases following COVID-19 vaccination.
Federica Fraenza, Cecilia Cagnotta, Mario Gaio, Liberata Sportiello, Cristina Scavone

Sci Rep· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oropharyngeal Adverse Events to Drugs and Vaccines: Pharmacovigilance Data From Italy (2019-2021).
Liberata Sportiello, Gaetano La Mantia, Vera Panzarella, Giuseppe Colella, Simona Potenza, Mario Gaio

Oral Dis· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of dapagliflozin and empagliflozin in cases with diabetes mellitus or/and heart failure: a retrospective pharmacovigilance study conducted on the eudravigilance database.
Annamaria Mascolo, Alessia Zinzi, Mario Gaio, Donatella Ruggiero, Cristina Scavone

Pharmacol Rep· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pregnancy Recommendations Solely Based on Preclinical Evidence Should Be Integrated with Real-World Evidence: A Disproportionality Analysis of Certolizumab and Other TNF-Alpha Inhibitors Used in Pregnant Patients with Psoriasis.
Mario Gaio, Maria Giovanna Vastarella, Maria Giuseppa Sullo, Cristina Scavone, Consiglia Riccardi

Pharmaceuticals (Basel)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Safety Profiles of Two First-Generation NTRK Inhibitors: Analysis of Individual Case Safety Reports from the FDA Adverse Event Reporting System (FAERS) Database.
Valerio Liguori, Mario Gaio, Alessia Zinzi, Cecilia Cagnotta, Consiglia Riccardi

Biomedicines· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Pharmacovigilance Study on the Safety of Axicabtagene Ciloleucel Based on Spontaneous Reports from the EudraVigilance Database.
Concetta Rafaniello, Valerio Liguori, Alessia Zinzi, Mario Gaio, Angela Falco

Biomedicines· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multisystem Inflammatory Syndrome in Children Following COVID-19 Vaccination: A Sex-Stratified Analysis of the VAERS Database Using Brighton Collaboration Criteria.
Valerio Liguori, Alessia Zinzi, Mario Gaio, Consiglia Riccardi, Luigi Di Costanzo

Pharmaceuticals (Basel)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 Vaccines and Atrial Fibrillation: Analysis of the Post-Marketing Pharmacovigilance European Database.
Rosanna Ruggiero, Maria Donniacuo, Annamaria Mascolo, Mario Gaio, Donato Cappetta

Biomedicines· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late relapse after CAR-T cell therapy for adult patients with hematologic malignancies: A definite evidence from systematic review and meta-analysis on individual data.
Alessia Zinzi, Mario Gaio, Valerio Liguori, Cecilia Cagnotta, Donatella Paolino

Pharmacol Res· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety Monitoring of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years by Using EudraVigilance Pharmacovigilance Database: The CoVaxChild Study.
Alessia Zinzi, Mario Gaio, Valerio Liguori, Rosanna Ruggiero, Marina Tesorone

Vaccines (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maternal, fetal and neonatal outcomes among pregnant women receiving COVID-19 vaccination: The preg-co-vax study.
Annamaria Mascolo, Gabriella di Mauro, Federica Fraenza, Mario Gaio, Alessia Zinzi

Front Immunol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Did the COVID-19 Pandemic Affect Contrast Media-Induced Adverse Drug Reaction's Reporting? A Pharmacovigilance Study in Southern Italy.
Claudia Rossi, Rosanna Ruggiero, Liberata Sportiello, Ciro Pentella, Mario Gaio

J Clin Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disentangling a Thorny Issue: Myocarditis and Pericarditis Post COVID-19 and Following mRNA COVID-19 Vaccines.
Concetta Rafaniello, Mario Gaio, Alessia Zinzi, Maria Giuseppa Sullo, Valerio Liguori

Pharmaceuticals (Basel)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Reporting Frequency of Ketoacidosis Events with Dapagliflozin from the European Spontaneous Reporting System: The DAPA-KETO Study.
Gabriella di Mauro, Annamaria Mascolo, Mario Gaio, Concetta Rafaniello, Antonella De Angelis

Pharmaceuticals (Basel)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Direct Oral Anticoagulants (DOACs) and Warfarin With Haemorrhagic Risk by Applying Correspondence Analysis to Data From the Italian Pharmacovigilance Database - A Case Study.
Mario Gaio, Carmen Ferrajolo, Alessia Zinzi, Consiglia Riccardi, Pasquale Di Filippo

Front Pharmacol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac Events Potentially Associated to Remdesivir: An Analysis from the European Spontaneous Adverse Event Reporting System.
Concetta Rafaniello, Carmen Ferrajolo, Maria Giuseppa Sullo, Mario Gaio, Alessia Zinzi

Pharmaceuticals (Basel)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance Database.
Gabriella di Mauro, Alessia Zinzi, Cristina Scavone, Annamaria Mascolo, Mario Gaio

Drug Saf· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tisagenlecleucel in Children and Young Adults: Reverse Translational Research by Using Real-World Safety Data.
Concetta Rafaniello, Carmen Ferrajolo, Mario Gaio, Alessia Zinzi, Cristina Scavone

Pharmaceuticals (Basel)· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis